SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BIOMIRA RESEARCH (BIOM)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: chirodoc who wrote ()2/24/2000 11:41:00 PM
From: chirodoc  Read Replies (1) of 72
 
BIOMIRA PROGRESS AT BIOTECHNOLOGY INDUSTRY ORGANIZATION
CONFERENCE

Biomira Inc. (BIOM) today presented at the Biotechnology Industry
Organizations' second annual CEO & Investor Conference, highlighting the
Company's clinical and financing developments.

"We now have three major cancer vaccine product candidates plus an immune
enhancer in the clinic and up to $100 million in financing potentially
available to push our products through to commercialization," commented
President and CEO Alex McPherson, MD, Ph.D., who spoke at the conference
today. "Biomira is addressing the largest cancer markets with innovative
product candidates. Theratope vaccine for metastatic breast cancer is now
in a pivotal Phase III trial, and BLP25 for lung cancer is in Phase II
testing. Our patient-specific vaccine for lymphoma, co-developed with
Biovector Therapeutics of Toulouse, France and the National Cancer
Institute (NCI), entered NCI-sponsored Phase I trials in the first half of
last year. We have a talented scientific staff and a strategically minded
and dedicated management team that should be credited with our progress
and success."

COMMENT: We have already expounded on Biomira in this issue. We include
this to allow newer readers to glean a little information on the company,
and to give long-time readers a little insight into what went down at the
Biotechnology Industry Organization Conference.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News